Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
GBP 876M -
Notice Type:
Contract Notice
Published Date:
08 March 2022
Closing Date:
12 April 2022
Location(s):
UK UNITED KINGDOM
UKD NORTH WEST (ENGLAND) (UK UNITED KINGDOM)
Description:
NHS South of England Branded Medicines - Tranche B and Annual

NHS South of England Branded Medicines - Tranche B

Offer reference number: CM/PHR/20/5611

CM/PHR/20/5611/01 - NHS Framework for SOUTH of England Branded Medicines - Tranche B. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months

CM/PHR/20/5611/02 - NHS Framework for the SOUTH of England Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months


CM/PHR/20/5611/01 - NHS Framework for SOUTH of England Branded - Tranche B

CM/PHR/20/5611/01 - NHS Framework for SOUTH of England Branded Medicines - Tranche B. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months


CM/PHR/20/5611/02 - NHS Framework for the SOUTH of England Branded - Annual

CM/PHR/20/5611/02 - NHS Framework for the SOUTH of England Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months

Download full details as .pdf
The Buyer:
The NHS Commissioning Board (operating under the name of NHS England)
CPV Code(s):
33600000 - Pharmaceutical products